Recordati Industria Chimica e Farmaceutica S.p.A. RCDTF 40.93 Recordati Industria Chimica e Farmaceutica S.p.A.

Home
⇒ 
Stock List ⇒ Recordati Industria Chimica e Farmaceutica S.p.A.
Range:46.0-52.25Vol Avg:9Last Div:1.37Changes:2.25
Beta:0.4Cap:10.78BCurrency:USDExchange:PNK
Sector:HealthcareIPO:Fri Dec 17 2010Empoloyees:4450
CUSIP:CIK:ISIN:IT0003828271Country:IT
CEO:Dr. Robert Koremans M.D.Website:https://www.recordati.com
Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Stock Details

The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow